Antidiabetic Effects of the Senolytic Agent Dasatinib

Unrelated to rapamycin, but many people are already using the cancer drug Dasatinib as a senolytic, based on the Mayo Clinic research. This new discovery makes it an even more interesting drug in terms of anti-aging.

Full Paper: Antidiabetic Effects of the Senolytic Agent Dasatinib